Medical Conditions Causing Elevated Hemoglobin, Hematocrit, and Red Blood Cell Count
Elevated hemoglobin, hematocrit, and RBC count result from either primary bone marrow disorders (polycythemia vera), secondary causes driven by hypoxia or inappropriate erythropoietin production, or relative polycythemia from plasma volume depletion. 1, 2
Primary Polycythemia
Polycythemia Vera (PV)
- PV is a myeloproliferative neoplasm where the bone marrow produces excessive red blood cells independent of normal regulatory mechanisms. 3, 4
- More than 95% of PV patients carry a JAK2 gene mutation (either exon 14 or exon 12), which distinguishes it from secondary causes. 2, 3
- Diagnostic thresholds per WHO 2016 criteria: hemoglobin >16.5 g/dL (men) or >16.0 g/dL (women); hematocrit >49% (men) or >48% (women). 4
- Associated features include thrombocytosis (53%), leukocytosis (49%), splenomegaly (36%), pruritus (33%), and erythromelalgia (5.3%). 3
- Patients face 16% risk of arterial thrombosis and 7% risk of venous thrombosis (including unusual sites like splanchnic veins) at or before diagnosis. 3
Other Primary Causes
- Activating mutations of the erythropoietin receptor (EPOR) cause congenital polycythemia. 1
- High-oxygen-affinity hemoglobin variants (autosomal dominant) and 2,3-diphosphoglycerate mutase deficiency (autosomal recessive) are rare genetic causes. 1, 2
- Chuvash polycythemia results from von Hippel-Lindau gene mutations causing abnormal oxygen homeostasis. 1, 2
Secondary Polycythemia: Hypoxia-Driven
Chronic Lung Disease
- Chronic obstructive pulmonary disease (COPD) causes compensatory erythrocytosis through chronic tissue hypoxia stimulating erythropoietin production. 1
- Interstitial lung disease and other restrictive/obstructive pulmonary diseases trigger similar compensatory mechanisms. 1
Smoking-Related Polycythemia
- "Smoker's polycythemia" results from chronic carbon monoxide exposure, which binds hemoglobin, creates functional hypoxia, and stimulates erythropoietin production. 1, 2, 5
- In hypoxic COPD patients, cigarette smoking significantly increases red cell mass (mean 42.5 ml/kg in smokers vs 29.7 ml/kg in nonsmokers, p<0.01). 5
- Carboxyhemoglobin levels correlate strongly with red cell mass in smokers with COPD. 5
- This condition resolves with smoking cessation. 2
Sleep-Disordered Breathing
- Obstructive sleep apnea produces nocturnal hypoxemia that drives erythropoietin production and secondary erythrocytosis. 1, 2
- Alveolar hypoventilation disorders cause similar hypoxia-driven erythrocytosis. 1
High Altitude Exposure
- Chronic exposure to high altitude causes physiologic erythrocytosis as adaptation to reduced atmospheric oxygen. 1
- Hemoglobin increases predictably with altitude: +0.2 g/dL at 1,000 meters, +0.8 g/dL at 2,000 meters, +1.9 g/dL at 3,000 meters, and +4.5 g/dL at 4,500 meters. 2
- Diagnostic thresholds for PV must be adjusted for altitude of residence to avoid misdiagnosis. 2
Cyanotic Congenital Heart Disease
- Right-to-left cardiac shunts cause arterial hypoxemia, triggering compensatory erythrocytosis to optimize oxygen transport. 1, 2
- Eisenmenger's syndrome represents severe pulmonary vascular resistance elevation with shunt reversal, cyanosis, and secondary erythrocytosis. 1
Other Hypoxic Causes
- Renal artery stenosis creates localized renal hypoxia stimulating erythropoietin production. 1
- Carbon monoxide poisoning (acute or chronic) causes functional hypoxia. 1
Secondary Polycythemia: Hypoxia-Independent (Pathologic EPO Production)
Malignant Tumors
- Renal cell carcinoma produces erythropoietin autonomously, independent of oxygen sensing mechanisms. 1, 2
- Hepatocellular carcinoma can cause inappropriate erythropoietin secretion. 1, 2
- Cerebellar hemangioblastoma produces erythropoietin ectopically. 1, 2
- Parathyroid carcinoma may secrete erythropoietin. 1
Benign Conditions
- Uterine leiomyomas (fibroids) can produce erythropoietin. 1, 2
- Renal cysts and polycystic kidney disease cause local hypoxia or inappropriate EPO production. 1, 2
- Pheochromocytoma may be associated with erythrocytosis. 1, 2
- Meningioma can produce erythropoietin. 1, 2
Drug-Associated Causes
- Testosterone therapy and other androgen preparations stimulate erythropoiesis and commonly cause erythrocytosis. 1, 2
- Exogenous erythropoietin administration (EPO doping or therapeutic use) directly increases red cell production. 1, 2
Relative Polycythemia (Apparent Polycythemia)
Plasma Volume Depletion
- Dehydration causes hemoconcentration with elevated hemoglobin/hematocrit but normal total red cell mass. 1, 2
- Diuretic use reduces plasma volume, creating relative erythrocytosis. 2
- Burns cause plasma loss and hemoconcentration. 2
- Stress polycythemia (Gaisböck syndrome) involves chronic plasma volume contraction. 2
Hematologic Disorders
Myeloproliferative Disorders
- Chronic myeloproliferative disorders beyond PV can present with erythrocytosis. 1
- Post-splenectomy state may cause reactive erythrocytosis. 1
Hemolytic Anemias
- Chronic hemolytic anemia can paradoxically present with elevated reticulocyte counts and compensatory erythroid hyperplasia. 1
Critical Diagnostic Algorithm
When evaluating erythrocytosis, first exclude relative polycythemia by assessing hydration status, then measure serum erythropoietin levels to differentiate primary (low/normal EPO) from secondary causes (elevated EPO in hypoxia-driven cases, variable in tumor-related cases). 2
- If EPO is low or inappropriately normal with elevated hemoglobin, test for JAK2 mutations to diagnose PV. 2, 3
- If EPO is elevated, systematically evaluate for hypoxic causes: obtain smoking history, assess for sleep apnea with sleep study, check pulmonary function tests for COPD, and consider altitude of residence. 2
- If no hypoxic cause identified with elevated EPO, image kidneys and liver for EPO-secreting tumors. 2
- Always check iron studies (ferritin, transferrin saturation), as iron deficiency commonly coexists with erythrocytosis and can mask the diagnosis. 2
Common Pitfalls
- Do not diagnose PV using standard thresholds in high-altitude residents without adjusting for physiologic altitude adaptation. 2
- Do not perform therapeutic phlebotomy unless hematocrit exceeds 65% with hyperviscosity symptoms or PV is confirmed (target <45% in PV). 2, 3
- Do not overlook smoking history—even in patients with lung disease, smoking independently elevates red cell mass through carboxyhemoglobin. 5
- Do not miss testosterone use (prescribed or unprescribed) as a reversible cause, particularly in younger adults. 2